vs
Side-by-side financial comparison of JOINT Corp (JYNT) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $15.2M, roughly 1.2× JOINT Corp). JOINT Corp runs the higher net margin — 6.5% vs -3.0%, a 9.6% gap on every dollar of revenue. On growth, JOINT Corp posted the faster year-over-year revenue change (3.1% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $334.7K). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-10.1% CAGR vs -28.6%).
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
JYNT vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.2M | $18.3M |
| Net Profit | $991.1K | $-554.0K |
| Gross Margin | 81.4% | 21.1% |
| Operating Margin | 4.9% | -2.2% |
| Net Margin | 6.5% | -3.0% |
| Revenue YoY | 3.1% | -25.6% |
| Net Profit YoY | 5510.5% | 26.7% |
| EPS (diluted) | $0.06 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.2M | $18.3M | ||
| Q3 25 | $13.4M | $15.9M | ||
| Q2 25 | $13.3M | $16.1M | ||
| Q1 25 | $13.1M | $18.9M | ||
| Q4 24 | $14.7M | $24.7M | ||
| Q3 24 | $30.2M | $28.3M | ||
| Q2 24 | $30.3M | $25.8M | ||
| Q1 24 | $29.7M | $22.7M |
| Q4 25 | $991.1K | $-554.0K | ||
| Q3 25 | $855.0K | $-1.8M | ||
| Q2 25 | $93.4K | $-1.5M | ||
| Q1 25 | $967.8K | $-1.5M | ||
| Q4 24 | $17.7K | $-756.0K | ||
| Q3 24 | $-3.2M | $1.7M | ||
| Q2 24 | $-3.6M | $343.0K | ||
| Q1 24 | $947.0K | $-1.7M |
| Q4 25 | 81.4% | 21.1% | ||
| Q3 25 | 80.1% | 14.3% | ||
| Q2 25 | 79.1% | 15.6% | ||
| Q1 25 | 77.3% | 16.1% | ||
| Q4 24 | 78.4% | 14.7% | ||
| Q3 24 | 90.7% | 22.0% | ||
| Q2 24 | 90.7% | 17.6% | ||
| Q1 24 | 90.9% | 13.5% |
| Q4 25 | 4.9% | -2.2% | ||
| Q3 25 | 1.2% | -9.9% | ||
| Q2 25 | -8.6% | -8.4% | ||
| Q1 25 | -5.2% | -7.2% | ||
| Q4 24 | 5.5% | -2.1% | ||
| Q3 24 | -1.6% | 6.8% | ||
| Q2 24 | -5.9% | 2.0% | ||
| Q1 24 | -1.4% | -5.8% |
| Q4 25 | 6.5% | -3.0% | ||
| Q3 25 | 6.4% | -11.0% | ||
| Q2 25 | 0.7% | -9.3% | ||
| Q1 25 | 7.4% | -8.0% | ||
| Q4 24 | 0.1% | -3.1% | ||
| Q3 24 | -10.5% | 5.9% | ||
| Q2 24 | -11.9% | 1.3% | ||
| Q1 24 | 3.2% | -7.6% |
| Q4 25 | $0.06 | $-0.01 | ||
| Q3 25 | $0.06 | $-0.05 | ||
| Q2 25 | $0.01 | $-0.05 | ||
| Q1 25 | $0.06 | $-0.04 | ||
| Q4 24 | $0.01 | $-0.02 | ||
| Q3 24 | $-0.21 | $0.04 | ||
| Q2 24 | $-0.24 | $0.01 | ||
| Q1 24 | $0.06 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.6M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.1M | $37.0M |
| Total Assets | $61.0M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.6M | $10.7M | ||
| Q3 25 | $29.7M | $13.6M | ||
| Q2 25 | $29.8M | $12.5M | ||
| Q1 25 | $21.9M | $11.4M | ||
| Q4 24 | $25.1M | $15.7M | ||
| Q3 24 | $20.7M | $12.3M | ||
| Q2 24 | $17.5M | $11.9M | ||
| Q1 24 | $18.7M | $6.6M |
| Q4 25 | $15.1M | $37.0M | ||
| Q3 25 | $22.7M | $37.0M | ||
| Q2 25 | $23.2M | $30.4M | ||
| Q1 25 | $22.8M | $31.5M | ||
| Q4 24 | $20.7M | $32.6M | ||
| Q3 24 | $20.5M | $29.1M | ||
| Q2 24 | $23.2M | $23.5M | ||
| Q1 24 | $26.2M | $20.6M |
| Q4 25 | $61.0M | $57.1M | ||
| Q3 25 | $69.4M | $57.5M | ||
| Q2 25 | $73.2M | $52.6M | ||
| Q1 25 | $80.1M | $54.0M | ||
| Q4 24 | $83.2M | $59.2M | ||
| Q3 24 | $79.6M | $57.1M | ||
| Q2 24 | $82.4M | $53.0M | ||
| Q1 24 | $85.7M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $2.3M |
| Free Cash FlowOCF − Capex | $334.7K | $2.2M |
| FCF MarginFCF / Revenue | 2.2% | 12.0% |
| Capex IntensityCapex / Revenue | 9.9% | 0.5% |
| Cash ConversionOCF / Net Profit | 1.86× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.9M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8M | $2.3M | ||
| Q3 25 | $1.8M | $-1.3M | ||
| Q2 25 | $868.6K | $1.8M | ||
| Q1 25 | $-3.7M | $-3.5M | ||
| Q4 24 | $9.4M | $865.0K | ||
| Q3 24 | $3.4M | $4.3M | ||
| Q2 24 | $-973.5K | $1.4M | ||
| Q1 24 | $2.8M | $-2.4M |
| Q4 25 | $334.7K | $2.2M | ||
| Q3 25 | $1.5M | $-1.5M | ||
| Q2 25 | $363.6K | $1.7M | ||
| Q1 25 | $-4.0M | $-3.5M | ||
| Q4 24 | $8.2M | $470.0K | ||
| Q3 24 | $3.2M | $4.1M | ||
| Q2 24 | $-1.2M | $1.2M | ||
| Q1 24 | $2.4M | $-2.5M |
| Q4 25 | 2.2% | 12.0% | ||
| Q3 25 | 10.9% | -9.6% | ||
| Q2 25 | 2.7% | 10.5% | ||
| Q1 25 | -30.8% | -18.8% | ||
| Q4 24 | 55.9% | 1.9% | ||
| Q3 24 | 10.6% | 14.4% | ||
| Q2 24 | -4.1% | 4.5% | ||
| Q1 24 | 8.1% | -11.1% |
| Q4 25 | 9.9% | 0.5% | ||
| Q3 25 | 2.4% | 1.4% | ||
| Q2 25 | 3.8% | 1.0% | ||
| Q1 25 | 2.5% | 0.3% | ||
| Q4 24 | 8.1% | 1.6% | ||
| Q3 24 | 0.8% | 0.7% | ||
| Q2 24 | 0.9% | 1.1% | ||
| Q1 24 | 1.3% | 0.6% |
| Q4 25 | 1.86× | — | ||
| Q3 25 | 2.07× | — | ||
| Q2 25 | 9.30× | — | ||
| Q1 25 | -3.82× | — | ||
| Q4 24 | 532.98× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | 2.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
